Peters P W, Verburg H
Tijdschr Diergeneeskd. 1987 Apr 15;112(8):486-90.
The responsibility of the Ministry of Welfare, Health and Cultural Affairs (WVC) and especially the task of the Veterinary Public Health Inspectorate (VI), and the research and advice of the National Institute of Public Health and Environmental Hygiene (RIVM) are described with regard to the Netherlands Veterinary Medicinal Products Act, now and in the future. The registration of these medicines is also necessary for the safety of the consumer; this holds both for the problems related to residues in products of animal origin, and for the problems with respect to bacterial resistance to antimicrobial drugs, because of therapeutic prescription of the same type of drugs in human patients. The admittance to the market of a veterinary drug will only take place after an adequate risk-evaluation with respect to human health, followed by risk-management; the latter implies the admittance policy and its control. The authors have the opinion that the internal quality control and quality assurance during the meat production chain has to be conducted by the producers themselves. The monitoring of this surveillance, and hence the external quality assurance, will remain a governmental responsibility to safeguard products of animal origin.
阐述了荷兰福利、卫生和文化事务部(WVC)的职责,尤其是兽医公共卫生检查局(VI)的任务,以及国家公共卫生和环境卫生研究所(RIVM)目前和未来在《荷兰兽药产品法》方面的研究与建议。这些药品的注册对于消费者安全也很有必要;这既适用于与动物源性产品残留相关的问题,也适用于因人类患者使用同类药物进行治疗处方而导致的细菌对抗菌药物耐药性问题。兽药只有在对人类健康进行充分风险评估并随后进行风险管理之后才会进入市场;后者意味着准入政策及其管控。作者认为肉类生产链中的内部质量控制和质量保证必须由生产商自行开展。对这种监督的监测以及因此进行的外部质量保证,仍将是政府保障动物源性产品安全的职责。